Jump to Content

Key personnel

Prof Kerin O'Dea, Director, Sansom InstituteProfessor Kerin O'Dea
Director
Professor O'Dea took up the position as Director of the Sansom Institute for Health Research in early 2009. Her current research examines diet and lifestyle in the prevention and treatment of non-communicable diseases (obesity, type 2 diabetes and cardiovascular diseases), with a focus on elucidating the causal pathways and identifying critical intervention points. She has a particular interest in the therapeutic potential of traditional diets - especially Aboriginal hunter-gatherer and Mediterranean diets - and is committed to a research approach that spans the spectrum from the basic biomedical to the population, and includes quantitative and qualitative methodologies.

Professor O'Dea has held a number of senior academic and research leadership positions over the past 20 years, including Director of the Menzies Institute of Health Research in Darwin (2000-2005) and has been an active part of numerous national committees over many years advising government on health and medical research, Indigenous health, nutrition, and diabetes.



Professor Allan EvansProfessor Allan Evans
Pro Vice Chancellor, Division of Health Sciences
Professor Evans has been an academic at UniSA since 1992, taking on various leadership positions and being promoted to Professor in Pharmaceutics in 2003. In 2004 Allan became Head of the School of Pharmacy and Medical Science and played an instrumental role in establishing the Sansom Institute (now the Division-based Sansom Institute for Health Research) and in supporting tremendous growth in the school's research activity and teaching profile.

Professor Evans has a significant research career. He has more than 90 peer-reviewed publications with over 1,200 literature citations and has held NHMRC and/or ARC grants on an ongoing basis since 1994. With broad research interests including basic, clinical and commercial research into the better use of medicines, as well as the development of new ways of using medicines to treat skin cancer and kidney disease, Professor Evan's group has attracted over $15 million in Category 1-4 research income to UniSA. He continues to manage a number of exciting research projects, which regularly lead to invited lectures at overseas conferences.

Professor Evans is currently non-executive Director of two spin-off companies that he helped to form, PharmaQest Pte Ltd and CPR Pharma Services Ltd, and has a keen interest in supporting further engagement between the researchers of the Division and the health, innovation, and medical diagnostic industries. He has continued to teach Pharmacokinetics and Biopharmaceutics P 201 and as a former UniSA course coordinator and program director, is well placed to continue developing the Division's excellent array of undergraduate and postgraduate programs in health and medical sciences.



Rachael Penning-BourneRachael Penning-Bourne
Institute Manager
With a background in health and business and wide-ranging experience in the tertiary research sector in Australia and abroad, Rachael Penning-Bourne is responsible for managing the operations of the Institute. As well as driving the Sansom's strategic and marketing activities, Rachael works closely with researchers and external stakeholders on a range of business development activities including business plans and governance.

 

 

top^